Thanks for the measured replies. I was probably a bit out of...

First 167 Last

Share
Profile

Follow
HonyakuKonyaku

662 Posts.

332

01/11/18

08:03

Post #: 36344044
Share

Originally posted by razi: ↑

True that we anxiously waited (for what seemed like an eternity) for CFDA & exhaled mightily when it seemed to arrive. And, yes, probably most of us were disappointed that the SP rose "only" 10% when trading resumed (I certainly was, having seen that it opened at 0.45 upon going to sleep & then seeing a green 0.375 upon awakening...which almost had a reddish tint to it). That said, it's apt to be a long & winding road ahead...requiring considerable patience & continued belief in the essential nature/vision of the what GMV strives to offer. Unlike the recreational/faddish "toys" VR & Kinect, the Prizma/Patch & call centers address a clear universal health need that could/should appeal to almost anyone, anywhere. CFDA was never the end game...just a MAJOR obstacle along the way that needed to be overcome. And now that the path has been cleared, generating revenue will have to follow if the venture is to succeed. That could take MANY months to happen (or perhaps never). Big-agenda startups, like ours, typically need more time than others to unfold...but things DO seem to be progressing in the right direction -- even if more slowly than what most of us would prefer. If long-term, like me, I suggest trying to chill, appreciating the not inconsequential progress already made, retaining faith in the concept/products/services & in Dr. Geva's knowing how to get the job done. Best wishes to all...

Expand

Thanks for the measured replies. I was probably a bit out of line with my post. Nasdaq had a good session so maybe there will be a bit more appetite for risk today.

GMV Price at posting: 37.5¢ Sentiment: Hold Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 437 more messages in this thread...

First 167 Last

Add GMV (ASX) to my watchlist

Thanks for the measured replies. I was probably a bit out of...

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News